China Shineway Pharmaceutical publishes 2025 Annual Report, AGM documents and ESG Report

Bulletin Express
04/23

On 24 April 2026, China Shineway Pharmaceutical Group Limited announced that the English and Chinese versions of its 2025 Annual Report, the Circular and Notice of the forthcoming Annual General Meeting, as well as the related Proxy Form, are now accessible on both the company’s website (www.shineway.com.hk) and HKEXnews (www.hkexnews.hk).

In parallel, the Environmental, Social and Governance Report 2025 has been released and can be downloaded from the same online platforms under the “Investor Relations” section.

Registered shareholders who prefer hard copies of the newly published materials—or any future corporate communications—can request printed versions by:

• Submitting a written notice at least 10 days in advance to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited, 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai, Hong Kong; • Sending an email to ChinaShineway.ecom@computershare.com.hk, indicating name, address and the specific request; or • Calling the registrar’s customer service hotline at (852) 2862 8555 between 9:00 a.m. and 6:00 p.m. (Hong Kong time), Monday to Friday, excluding public holidays.

The notification was issued by Company Secretary Lee Bun Ching Terence on behalf of China Shineway Pharmaceutical Group Limited.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10